Huntsman (HUN) Stock
Global chemical producer supplying materials for construction and packaging. Here's the price, business snapshot, and what's worth knowing about Huntsman in October 2026.
Huntsman Corporation (HUN) is a global chemical manufacturer specialising in performance products and advanced materials used across automotive, construction, packaging and consumer markets. With a market capitalisation around $1.43 billion, it sits in the small-cap segment where operational moves and commodity cycles can drive notable share-price volatility. Key investor considerations include cyclicality of end-markets, sensitivity to raw-material and energy costs, and the company’s efforts to shift toward higher-margin speciality chemicals. Huntsman operates internationally, so currency and global demand trends matter. Financial health, free-cash-flow generation, and debt levels are important when assessing resilience in weaker economic conditions. Prior to any decision, investors should review the latest quarterly results, management guidance and sector outlook. This summary is for educational purposes only and not personalised investment advice — values can rise or fall and past performance does not guarantee future returns. Consider suitability for your goals and, if uncertain, consult a regulated adviser.
Huntsman (HUN) Stock Forecast
Analyst price target, next 12 months
$17.74
+101.6% vs today's $8.80
Price range over the last 12 months
Close to its 12-month low
Analysts covering Huntsman have a consensus 12-month target of $17.74, above the current price of $8.80.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest keeping Huntsman's stock as it has potential to rise, but remains cautious.
Financial Health
Huntsman is generating stable revenue and cash flow, but faces challenges in profitability.
Dividend
Huntsman's dividend yield of 5.82% offers a good return for dividend-seeking investors. If you invested $1000 you would be paid $51.00 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Cyclical demand dynamics
Industrial exposure means revenue can track global economic cycles; growth in end markets can boost sales but performance can also swing during slowdowns.
Commodity cost sensitivity
Feedstock and energy prices materially affect margins; effective procurement and pricing strategies matter, though costs can remain unpredictable.
Global operations impact
International footprint offers market access but adds currency and regulatory complexity; monitor regional demand and policy shifts when assessing outlook.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
